H

HLB Life Science Co Ltd
KOSDAQ:067630

Watchlist Manager
HLB Life Science Co Ltd
KOSDAQ:067630
Watchlist
Price: 8 280 KRW 0.36% Market Closed
Market Cap: 982.1B KRW
Have any thoughts about
HLB Life Science Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one HLB Life Science Co Ltd stock under the Base Case scenario is 2 184.52 KRW. Compared to the current market price of 8 280 KRW, HLB Life Science Co Ltd is Overvalued by 74%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 184.52 KRW
Overvaluation 74%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
HLB Life Science Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HLB Life Science Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HLB Life Science Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about HLB Life Science Co Ltd

Provide an overview of the primary business activities
of HLB Life Science Co Ltd.

What unique competitive advantages
does HLB Life Science Co Ltd hold over its rivals?

What risks and challenges
does HLB Life Science Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for HLB Life Science Co Ltd.

Provide P/S
for HLB Life Science Co Ltd.

Provide P/E
for HLB Life Science Co Ltd.

Provide P/OCF
for HLB Life Science Co Ltd.

Provide P/FCFE
for HLB Life Science Co Ltd.

Provide P/B
for HLB Life Science Co Ltd.

Provide EV/S
for HLB Life Science Co Ltd.

Provide EV/GP
for HLB Life Science Co Ltd.

Provide EV/EBITDA
for HLB Life Science Co Ltd.

Provide EV/EBIT
for HLB Life Science Co Ltd.

Provide EV/OCF
for HLB Life Science Co Ltd.

Provide EV/FCFF
for HLB Life Science Co Ltd.

Provide EV/IC
for HLB Life Science Co Ltd.

Compare the intrinsic valuations
of HLB Life Science Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of HLB Life Science Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of HLB Life Science Co Ltd compared to its peers.

Compare the P/E ratios
of HLB Life Science Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing HLB Life Science Co Ltd with its peers.

Analyze the financial leverage
of HLB Life Science Co Ltd compared to its main competitors.

Show all profitability ratios
for HLB Life Science Co Ltd.

Provide ROE
for HLB Life Science Co Ltd.

Provide ROA
for HLB Life Science Co Ltd.

Provide ROIC
for HLB Life Science Co Ltd.

Provide ROCE
for HLB Life Science Co Ltd.

Provide Gross Margin
for HLB Life Science Co Ltd.

Provide Operating Margin
for HLB Life Science Co Ltd.

Provide Net Margin
for HLB Life Science Co Ltd.

Provide FCF Margin
for HLB Life Science Co Ltd.

Show all solvency ratios
for HLB Life Science Co Ltd.

Provide D/E Ratio
for HLB Life Science Co Ltd.

Provide D/A Ratio
for HLB Life Science Co Ltd.

Provide Interest Coverage Ratio
for HLB Life Science Co Ltd.

Provide Altman Z-Score Ratio
for HLB Life Science Co Ltd.

Provide Quick Ratio
for HLB Life Science Co Ltd.

Provide Current Ratio
for HLB Life Science Co Ltd.

Provide Cash Ratio
for HLB Life Science Co Ltd.

What is the historical Revenue growth
over the last 5 years for HLB Life Science Co Ltd?

What is the historical Net Income growth
over the last 5 years for HLB Life Science Co Ltd?

What is the current Free Cash Flow
of HLB Life Science Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for HLB Life Science Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
HLB Life Science Co Ltd

Current Assets 143.2B
Cash & Short-Term Investments 71.3B
Receivables 17.1B
Other Current Assets 54.7B
Non-Current Assets 350.5B
Long-Term Investments 214.2B
PP&E 83.5B
Intangibles 52.3B
Other Non-Current Assets 484.4m
Current Liabilities 67.9B
Accounts Payable 6.2B
Short-Term Debt 10.2B
Other Current Liabilities 51.4B
Non-Current Liabilities 66.8B
Long-Term Debt 62.1B
Other Non-Current Liabilities 4.8B
Efficiency

Earnings Waterfall
HLB Life Science Co Ltd

Revenue
92.9B KRW
Cost of Revenue
-95.4B KRW
Gross Profit
-2.5B KRW
Operating Expenses
-24.4B KRW
Operating Income
-27B KRW
Other Expenses
17.8B KRW
Net Income
-9.2B KRW

Free Cash Flow Analysis
HLB Life Science Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

HLB Life Science Co Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
ROE is Increasing
Declining ROIC
Negative ROE
24/100
Profitability
Score

HLB Life Science Co Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

HLB Life Science Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
61/100
Solvency
Score

HLB Life Science Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
HLB Life Science Co Ltd

There are no price targets for HLB Life Science Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HLB Life Science Co Ltd?

Click here to dive deeper.

Dividends

HLB Life Science Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for HLB Life Science Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

HLB Life Science Co Ltd

Country

Korea

Industry

Health Care

Market Cap

982B KRW

Dividend Yield

0%

Description

HLB Life Sciences Co., Ltd. engages in the provision of energy saving services. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2008-11-25. Along with subsidiaries, the Company operates its business through four segments. The Pharmaceutical Distribution segment is involved in the sale of pharmaceuticals and raw materials through SHINWHAADVANCE.CO.LTD. The Energy Business segment is engaged in energy service company (ESCO) business. The company is equipped with equipments, assets and technical personnel to engage in energy saving investment business. The Bio Development segment is engaged in the development of extracorporeal circulation type bio space, hepatocyte treatment agents and hemostatic agents. The main products include anticancer drugs such as Tegatrabetan and Seclidemstat. The Other Business segment is involved in the investment of small business start-ups and venture businesses, as well as manufacturing and sale of light emitting diode (LED) products.

Contact

GYEONGGI-DO
Hwaseong
8F, M Tower Knowledge Industry Center, 51-9, Dongtancheomdansaneop 1-ro
+82226276700
www.hlb-ls.com

IPO

2008-11-25

Employees

-

Officers

Chief Exec. Officer and Pres
Sung-Bo Sim

See Also

Discover More
What is the Intrinsic Value of one HLB Life Science Co Ltd stock?

The intrinsic value of one HLB Life Science Co Ltd stock under the Base Case scenario is 2 184.52 KRW.

Is HLB Life Science Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8 280 KRW, HLB Life Science Co Ltd is Overvalued by 74%.

Back to Top